Streetbeat News

Revenues

GKOS

Glaukos Corporation reported preliminary Q4 FY23 net sales exceeding $81M and over $313M for the full year FY23, surpassing consensus estimates of $76.69M for Q4 and $309.05M for the full year.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 12:08 pm

VNT

Vontier Corporation has sold its Coats business to Victor Capital Partners for $72.5 million in an all-cash deal. Coats is expected to generate $110 million in revenue and $10 million in EBITDA for 2023. The financial results of Coats are included in Vontier's 'Other' segment and will be removed from continuing operations from the transaction's completion date, January 8, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 12:05 pm

F

RIVN

TSLA

Tesla Inc.'s (NASDAQ:TSLA) price cuts in 2023 have significantly reduced the price gap between electric vehicles (EVs) and internal combustion engine (ICE) vehicles. Cox Automotive reports that by December, the average Tesla vehicle price was $50,051, close to the average ICE vehicle price of $48,759. The average EV price also dropped to $50,798. High inventory levels for EVs were reported, but Tesla and Rivian Automotive Inc. (NASDAQ:RIVN) were excluded from this data. The University of Exeter suggests EVs may become more affordable than gas vehicles in the U.S. this year. Ford Motor Co (NYSE:F) paused its $12 billion EV funding due to high EV costs and customer reluctance.

Portfolio Pulse from Ramakrishnan M

January 09, 2024 | 12:04 pm

EA

In the past three months, 7 analysts have provided ratings for Electronic Arts (NASDAQ:EA), with recent shifts in sentiment. The average 12-month price target is now $150.57, up 6.79% from the previous $141.00. Analysts from BMO Capital, Deutsche Bank, Roth MKM, JP Morgan, Wedbush, and Wells Fargo have adjusted their ratings and price targets, reflecting a positive outlook on EA's performance. EA's financials show a market cap above industry average, a revenue growth rate of 0.53%, a net margin of 20.85%, ROE of 5.35%, ROA of 3.04%, and a low debt-to-equity ratio of 0.26.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 12:01 pm

ALHC

Alignment Healthcare (NASDAQ:ALHC) has received mixed analyst ratings over the past three months, with 2 bullish and 3 indifferent ratings. The average 12-month price target is $9.45, up 11.18% from the previous $8.50. Analysts from Raymond James, UBS, B of A Securities, and Stephens & Co. have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Alignment Healthcare, a provider of Medicare Advantage plans, has shown a revenue growth of 26.74% as of September 30, 2023, but struggles with profitability and debt management, having a net margin of -7.67% and a debt-to-equity ratio of 0.91.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 12:01 pm

SNAP

Analysts have mixed views on Snap Inc. (NYSE:SNAP), with ratings ranging from bullish to bearish. Over the last quarter, there have been shifts in sentiment, with the most recent month showing a more cautious stance. The average 12-month price target is $13.9, up 57.42% from the previous $8.83, with a high estimate of $23.00 and a low of $7.00. Several analysts have raised their price targets, while others maintain or have a neutral stance. Snap's financials show a lower market cap compared to industry averages, a revenue growth of 5.32%, but struggles with profitability and debt management.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 12:01 pm

ANF

Abercrombie & Fitch (NYSE:ANF) has been analyzed by 8 analysts, showing a shift towards a more bullish sentiment with 4 somewhat bullish and 4 indifferent ratings. The average 12-month price target for ANF is now $78.88, up 14.55% from the previous target of $68.86. Analysts from Telsey Advisory Group, Citigroup, UBS, and Morgan Stanley have raised their price targets, reflecting positive expectations for the company's performance. Abercrombie & Fitch has demonstrated strong financial health with a 20.04% revenue growth rate, a net margin of 9.11%, an ROE of 11.77%, an ROA of 3.38%, and a conservative debt-to-equity ratio of 1.27.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 12:01 pm

FITB

Six analysts have recently updated their ratings for Fifth Third Bancorp (NASDAQ:FITB), with a mix of bullish and indifferent stances. The average 12-month price target is now $35.67, up 10.09% from the previous $32.40. Analysts from firms like Keefe, Bruyette & Woods, Barclays, Goldman Sachs, Wells Fargo, RBC Capital, and Morgan Stanley have adjusted their price targets and ratings, reflecting their latest views on the company's performance. Fifth Third Bancorp, a diversified financial-services company, has shown a slight revenue decline of -0.7% over 3 months but boasts a high net margin of 29.44% and an ROE of 4.14%, indicating strong profitability and financial management.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 12:00 pm

EXTR

Extreme Networks Inc (NASDAQ:EXTR) shares dropped over 6% after the company reduced its Q2 revenue guidance. The new forecast is between $294 million to $297 million, down from the previous range of $312 million to $327 million, and below the consensus estimate of $320.51 million. Despite a projected 41% Y/Y increase in subscription and support revenue, and an expectation for recurring revenue to make up 33% of total revenue, the company cited industry headwinds and longer sales cycles for the revision. The Q2 gross margin is expected to be at the higher end of the 59.5%-61.5% range. EXTR also repurchased $25 million in shares and reported a cash balance of $221.4 million. The Q2 earnings results will be announced on January 31, 2024.

Portfolio Pulse from Lekha Gupta

January 09, 2024 | 11:56 am

BNTX

BioNTech presented its strategic priorities for 2024 at the J.P. Morgan Healthcare Conference, aiming to have ten or more registrational trials by the end of 2024 and to be commercial-ready by the end of 2025. The company reported an unaudited €17.5 billion in cash and equivalents for 2023 and anticipates revenues of about €3 billion for 2024.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:46 am